Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04625257
What this trial is testing

COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)

Who this might be right for
Coronavirus Infectious Disease 2019 (COVID-19)
University Hospital, Basel, Switzerland 1,600
Not applicableUnknownNCT04351659
What this trial is testing

Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

Who this might be right for
COVID-19
KK Women's and Children's Hospital 8
Large-scale testing (Phase 3)Ended earlyNCT04327505
What this trial is testing

Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19

Who this might be right for
SARS (Severe Acute Respiratory Syndrome)Cytokine StormARDS, Human+3 more
Karolinska Institutet 34
Testing effectiveness (Phase 2)Study completedNCT04399980
What this trial is testing

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

Who this might be right for
COVID 19SARS-CoV 2Pneumonia
The Cleveland Clinic 40
Large-scale testing (Phase 3)Ended earlyNCT04257656
What this trial is testing

A Trial of Remdesivir in Adults With Severe COVID-19

Who this might be right for
COVID-19RemdesivirSARS-CoV-2
Capital Medical University 237
Large-scale testing (Phase 3)Ended earlyNCT04425629
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 10,078
Large-scale testing (Phase 3)Study completedNCT04843761
What this trial is testing

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 473
Large-scale testing (Phase 3)Ended earlyNCT04369469
What this trial is testing

Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia

Who this might be right for
COVID-19 Severe PneumoniaAcute Lung InjuryAcute Respiratory Distress Syndrome+1 more
Alexion Pharmaceuticals, Inc. 202
Not applicableStudy completedNCT05458557
What this trial is testing

Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Elizabeth Glaser Pediatric AIDS Foundation 5,000
Testing effectiveness (Phase 2)Study completedNCT04334044
What this trial is testing

Treatment of SARS Caused by COVID-19 With Ruxolitinib

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2
Grupo Cooperativo de Hemopatías Malignas 77
Early research (Phase 1)Study completedNCT05541861
What this trial is testing

Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 383
Early research (Phase 1)Study completedNCT05263921
What this trial is testing

Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Bioavailability
Pfizer 12
Post-approval studies (Phase 4)Study completedNCT04340557
What this trial is testing

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

Who this might be right for
SARS-CoV Infection
Sharp HealthCare 31
Not applicableEnded earlyNCT04566965
What this trial is testing

Serology to COVID-19 for Recording Exposures and Evaluating Needs

Who this might be right for
Covid19CoronavirusSARS-CoV Infection
Children's Hospital Medical Center, Cincinnati 232
Testing effectiveness (Phase 2)Study completedNCT04375098
What this trial is testing

Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Pontificia Universidad Catolica de Chile 58
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Not applicableUnknownNCT04438837
What this trial is testing

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Post-Exposure Prophylaxis
Rambam Health Care Campus 582
Large-scale testing (Phase 3)Study completedNCT06729593
What this trial is testing

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 87
Not applicableUnknownNCT04941079
What this trial is testing

Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients ：a Prospective Observational Study

Who this might be right for
Covid19Myopathy
First Affiliated Hospital of Chongqing Medical University 70
Large-scale testing (Phase 3)UnknownNCT04423042
What this trial is testing

Tocilizumab in Coronavirus-19 Positive Patients

Who this might be right for
Covid19COVID-19Severe Acute Respiratory Syndrome Coronavirus 2+2 more
University of Calgary 30
Next Page